AI could help lymphoma patients stick to their pills

NCT ID NCT07546188

Recruiting now Knowledge-focused Sponsor: Grand Hôpital de Charleroi Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests an artificial intelligence system designed to predict when lymphoma patients might not take their oral medications as prescribed. Researchers will enroll 210 adults with non-Hodgkin lymphoma and use AI to analyze patient data, aiming to catch non-compliance early. The goal is to improve care coordination and help doctors intervene before problems arise.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this could lead to a tool that helps doctors spot when lymphoma patients are not taking their oral medications as prescribed, allowing for timely support.
What could go wrong: This is an early-stage quality improvement study with only 210 participants. The AI model may not perform well enough in real-world settings, and results may not apply to other cancers or hospitals.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CARE COORDINATION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

lymphoma, non-Hodgkin, familial non-Hodgkin lymphoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CARE COORDINATION LYMPHOMA, NON-HODGKIN

Contacts and locations

Locations

Grand Hôpital de Charleroi
RECRUITING

Charleroi, Hainaut, 6060, Belgium

More trials for these conditions

Other studies related to the condition(s) this trial covers.